Non-Randomized Trials Okay For Atrial Fibrillation RF Ablation Trials - Panel
This article was originally published in The Gray Sheet
Executive Summary
Radiofrequency ablation catheters could be evaluated for treatment of atrial fibrillation (AFib) through non-randomized studies using patients as their own control, members of FDA's Circulatory System Devices Panel concluded at their July 21-22 meeting.
You may also be interested in...
Pacemaker, Ablation Atrial Fibrillation Studies Evaluated By FDA Panel
Quality of life endpoints are sufficient for approving implantable pacemakers and defibrillators as treatments for atrial fibrillation, even without assurances that the devices provide long-term clinical benefit, FDA's Circulatory Systems Device Panel concluded April 6 in Gaithersburg, Maryland.
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.